| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 5 |
| 1 | OXALIPLATIN | 4 |
| 2 | CAPECITABINE | 3 |
| 3 | ETOPOSIDE | 3 |
| 4 | FLUOROURACIL | 3 |
| 5 | FLUOROURACIL CREAM, 0.5% | 3 |
| 6 | IFOSFAMIDE | 3 |
| 7 | IFOSFAMIDE FOR INJECTION | 3 |
| 8 | LAMOTRIGINE | 2 |
| 9 | PACLITAXEL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOREMIFENE CITRATE | 1 | 0.0023 |
| 1 | CALCIUM FOLINATE | 1 | 0.0002 |
| 2 | TAMOXIFEN CITRATE | 1 | 0.0002 |
| 3 | IFOSFAMIDE FOR INJECTION | 3 | 0.0001 |
| 4 | CLADRIBINE | 1 | 0.0001 |
| 5 | DIPHENHYDRAMINE HCL | 1 | 0.0001 |
| 6 | GOSERELIN | 1 | 0.0001 |
| 7 | EVEROLIMUS TABLETS | 1 | 0.0001 |
| 8 | OXALIPLATIN | 4 | 0.0001 |
| 9 | PRAVASTATIN SODIUM | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 5 |
| 1 | Progestin-containing Intrauterine System [EPC] | 5 |
| 2 | Alkylating Drug [EPC] | 4 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 4 |
| 4 | Platinum-based Drug [EPC] | 4 |
| 5 | Topoisomerase Inhibitor [EPC] | 3 |
| 6 | Anti-epileptic Agent [EPC] | 2 |
| 7 | Estrogen [EPC] | 2 |
| 8 | Microtubule Inhibitor [EPC] | 2 |
| 9 | Mood Stabilizer [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 1 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Copper-containing Intrauterine Device [EPC] | 1 | 0.0000 |
| 3 | Progestin [EPC] | 5 | 0.0000 |
| 4 | Alkylating Drug [EPC] | 4 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 4 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 4 | 0.0000 |
| 7 | Microtubule Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |